{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:17:59Z","timestamp":1792570679050,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012331","name":"LEO Fondet","doi-asserted-by":"publisher","award":["LF-OC-19-000088"],"award-info":[{"award-number":["LF-OC-19-000088"]}],"id":[{"id":"10.13039\/501100012331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Little is known about employment status, occupation, and disposable income in adults with NF1.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From the Danish National Patient Registry and database of two national Centers for Rare Diseases, we identified 1469 adults with NF1, who were matched to 11,991 randomly selected population comparisons on sex and birth year and month. Annual information on employment, occupation and disposable income was ascertained from national registries in 1980\u20132019.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Adults with NF1 had a lower odds ratio (OR) for employment [OR 0.71, 95% confidence interval (CI) 0.61\u20130.83] and higher OR for health-related unemployment (OR 2.94, 95% CI 2.16\u20133.96) at age 30\u00a0years than population comparisons, which persisted at age 40 and 50\u00a0years. Somatic diagnoses were associated with a higher OR for health-related unemployment in adults with NF1 than in the population comparisons. Adults with NF1 had a slightly lower disposable income, with a 14% (0.82\u20130.89) reduction observed among the youngest birth cohort. Furthermore, adults with NF1 were less likely to be in a high skilled occupation at ages 30, 40 and 50\u00a0years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Adults with NF1 have a lower employment rate, which was mainly due to health-related reasons and a slightly lower disposable income than adults without NF1. Thus, anticipation guidance for employment should be part of the management of NF1 families.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-023-02965-2","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T15:02:00Z","timestamp":1699282920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Employment, occupation, and income in adults with neurofibromatosis 1 in Denmark: a population- and register-based cohort study"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3584-6570","authenticated-orcid":false,"given":"Line","family":"Kenborg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line E.","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Galanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline","family":"Doser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas T.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia Aagaard","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Hove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette M.","family":"Handrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie","family":"Ejerskov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Mulvihill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette F.","family":"Winther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,6]]},"reference":[{"key":"2965_CR1","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/jid.2014.465","volume":"135","author":"E Uusitalo","year":"2015","unstructured":"Uusitalo E, Leppavirta J, Koffert A, Suominen S, Vahtera J, Vahlberg T, et al. Incidence and mortality of neurofibromatosis: a total population study in Finland. J Invest Dermatol. 2015;135:904\u20136.","journal-title":"J Invest Dermatol"},{"key":"2965_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13023-020-1310-3","volume":"15","author":"C Bergqvist","year":"2020","unstructured":"Bergqvist C, Servy A, Valeyrie-Allanore L, Ferkal S, Combemale P, Wolkenstein P, et al. Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966. Orphanet J Rare Dis. 2020;15:37.","journal-title":"Orphanet J Rare Dis"},{"key":"2965_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/GIM.0b013e3181bf15e3","volume":"12","author":"K Jett","year":"2010","unstructured":"Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet Med. 2010;12:1\u201311.","journal-title":"Genet Med"},{"key":"2965_CR4","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/s41436-020-0769-6","volume":"22","author":"L Kenborg","year":"2020","unstructured":"Kenborg L, Duun-Henriksen AK, Dalton SO, Bidstrup PE, Doser K, Rugbjerg K, et al. Multisystem burden of neurofibromatosis 1 in Denmark: registry- and population-based rates of hospitalizations over the life span. Genet Med. 2020;22:1069\u201378.","journal-title":"Genet Med"},{"key":"2965_CR5","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1002\/ajmg.a.62436","volume":"185","author":"L Kenborg","year":"2021","unstructured":"Kenborg L, Andersen EW, Duun-Henriksen AK, Jepsen JRM, Doser K, Dalton SO, et al. Psychiatric disorders in individuals with neurofibromatosis 1 in Denmark: a nationwide register-based cohort study. Am J Med Genet A. 2021;185:3706\u201316.","journal-title":"Am J Med Genet A"},{"key":"2965_CR6","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","volume":"34","author":"E Uusitalo","year":"2016","unstructured":"Uusitalo E, Rantanen M, Kallionpaa RA, Poyhonen M, Leppavirta J, Yla-Outinen H, et al. Distinctive cancer associations in patients with neurofibromatosis type 1. J Clin Oncol. 2016;34:1978\u201386.","journal-title":"J Clin Oncol"},{"key":"2965_CR7","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/ajmg.a.61627","volume":"182","author":"K Doser","year":"2020","unstructured":"Doser K, Andersen EW, Kenborg L, Dalton SO, Jepsen JRM, Kroyer A, et al. Clinical characteristics and quality of life, depression, and anxiety in adults with neurofibromatosis type 1: a nationwide study. Am J Med Genet A. 2020;182:1704\u201315.","journal-title":"Am J Med Genet A"},{"key":"2965_CR8","first-page":"i141","volume":"2","author":"G Hamoy-Jimenez","year":"2020","unstructured":"Hamoy-Jimenez G, Kim R, Suppiah S, Zadeh G, Bril V, Barnett C. Quality of life in patients with neurofibromatosis type 1 and 2 in Canada. Neurooncol Adv. 2020;2:i141\u20139.","journal-title":"Neurooncol Adv"},{"key":"2965_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41431-019-0359-8","volume":"27","author":"K Doser","year":"2019","unstructured":"Doser K, Kenborg L, Andersen EW, Bidstrup PE, Kroyer A, Hove H, et al. Educational delay and attainment in persons with neurofibromatosis 1 in Denmark. Eur J Hum Genet. 2019;27:857\u201368.","journal-title":"Eur J Hum Genet"},{"key":"2965_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/cge.13907","volume":"99","author":"E Johansson","year":"2021","unstructured":"Johansson E, Kallionpaa RA, Bockerman P, Peltonen J, Peltonen S. A rare disease and education: neurofibromatosis type 1 decreases educational attainment. Clin Genet. 2021;99:529\u201339.","journal-title":"Clin Genet"},{"key":"2965_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/cge.12551","volume":"88","author":"JS Cohen","year":"2015","unstructured":"Cohen JS, Levy HP, Sloan J, Dariotis J, Biesecker BB. Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life. Clin Genet. 2015;88:425\u201330.","journal-title":"Clin Genet"},{"key":"2965_CR12","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/ajmg.a.31422","volume":"140","author":"PZ Page","year":"2006","unstructured":"Page PZ, Page GP, Ecosse E, Korf BR, Leplege A, Wolkenstein P. Impact of neurofibromatosis 1 on Quality of Life: a cross-sectional study of 176 American cases. Am J Med Genet A. 2006;140:1893\u20138.","journal-title":"Am J Med Genet A"},{"key":"2965_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13023-021-01866-6","volume":"16","author":"FD Buono","year":"2021","unstructured":"Buono FD, Sprong ME, Paul E, Martin S, Larkin K, Garakani A. The mediating effects of quality of life, depression, and generalized anxiety on perceived barriers to employment success for people diagnosed with Neurofibromatosis Type 1. Orphanet J Rare Dis. 2021;16:234.","journal-title":"Orphanet J Rare Dis"},{"key":"2965_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-023-01426-5","author":"RA Kallionp\u00e4\u00e4","year":"2023","unstructured":"Kallionp\u00e4\u00e4 RA, Johansson E, B\u00f6ckerman P, Peltonen J, Peltonen S. The contribution of morbidity and unemployment for the reduced labor market participation of individuals with neurofibromatosis 1 in Finland. Eur J Hum Genet. 2023. https:\/\/doi.org\/10.1038\/s41431-023-01426-5.","journal-title":"Eur J Hum Genet"},{"key":"2965_CR15","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.gim.2021.11.024","volume":"24","author":"E Johansson","year":"2022","unstructured":"Johansson E, Kallionpaa RA, Bockerman P, Peltonen S, Peltonen J. The rare disease neurofibromatosis 1 as a source of hereditary economic inequality: evidence from Finland. Genet Med. 2022;24:870\u20139.","journal-title":"Genet Med"},{"key":"2965_CR16","doi-asserted-by":"publisher","first-page":"e065340","DOI":"10.1136\/bmjopen-2022-065340","volume":"12","author":"K Doser","year":"2022","unstructured":"Doser K, Hove H, \u00d8stergaard JR, Bidstrup PE, Dalton SO, Handrup MM, et al. Cohort profile: life with neurofibromatosis 1\u2014the Danish NF1 cohort. BMJ Open. 2022;12:e065340.","journal-title":"BMJ Open"},{"key":"2965_CR17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","volume":"29","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Pedersen L, Sorensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29:541\u20139.","journal-title":"Eur J Epidemiol"},{"key":"2965_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/1403494811408483","volume":"39","author":"F Petersson","year":"2011","unstructured":"Petersson F, Baadsgaard M, Thygesen LC. Danish registers on personal labour market affiliation. Scand J Public Health. 2011;39:95\u20138.","journal-title":"Scand J Public Health"},{"key":"2965_CR19","unstructured":"Eurostat. Statistics explained. 2022. https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Glossary:At-risk-of-poverty_rate"},{"key":"2965_CR20","unstructured":"International Labour Office. International Standard Classification of Occupations (ISCO-08). 2022. https:\/\/www.ilo.org\/wcmsp5\/groups\/public\/---dgreports\/---dcomm\/---publ\/documents\/publication\/wcms_172572.pdf"},{"key":"2965_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/1403494810394715","volume":"39","author":"VM Jensen","year":"2011","unstructured":"Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health. 2011;39:91\u20134.","journal-title":"Scand J Public Health"},{"key":"2965_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1403494810393562","volume":"39","author":"ML Gjerstorff","year":"2011","unstructured":"Gjerstorff ML. The Danish cancer registry. Scand J Public Health. 2011;39:42\u20135.","journal-title":"Scand J Public Health"},{"key":"2965_CR23","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449\u201390.","journal-title":"Clin Epidemiol"},{"key":"2965_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/1403494810395825","volume":"39","author":"O Mors","year":"2011","unstructured":"Mors O, Perto GP, Mortensen PB. The Danish psychiatric central research register. Scand J Public Health. 2011;39:54\u20137.","journal-title":"Scand J Public Health"},{"key":"2965_CR25","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing. 2021. https:\/\/www.R-project.org\/"},{"key":"2965_CR26","unstructured":"OECD. Education at a Glance 2019: OECD Indicator. OECD Publishing; 2019."},{"key":"2965_CR27","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/s41431-022-01149-z","volume":"30","author":"K Doser","year":"2022","unstructured":"Doser K, Belmonte F, Andersen KK, Ostergaard JR, Hove H, Handrup MM, et al. School performance of children with neurofibromatosis 1: a nationwide population-based study. Eur J Hum Genet. 2022;30:1405\u201312.","journal-title":"Eur J Hum Genet"},{"key":"2965_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0022-510X(96)00022-6","volume":"138","author":"RE Ferner","year":"1996","unstructured":"Ferner RE, Hughes RA, Weinman J. Intellectual impairment in neurofibromatosis 1. J Neurol Sci. 1996;138:125\u201333.","journal-title":"J Neurol Sci"},{"key":"2965_CR29","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1177\/0883073808316366","volume":"23","author":"LC Krab","year":"2008","unstructured":"Krab LC, Aarsen FK, de Goede-Bolder A, Catsman-Berrevoets CE, Arts WF, Moll HA, et al. Impact of neurofibromatosis type 1 on school performance. J Child Neurol. 2008;23:1002\u201310.","journal-title":"J Child Neurol"},{"key":"2965_CR30","first-page":"504","volume":"69","author":"KW Fjermestad","year":"2019","unstructured":"Fjermestad KW. Health complaints and work experiences among adults with neurofibromatosis 1. Occup Med (Lond). 2019;69:504\u201310.","journal-title":"Occup Med (Lond)"},{"key":"2965_CR31","doi-asserted-by":"crossref","unstructured":"S\u00f8gaard JE, Roine J, Robling P-O, Pareliussen J, Orsetta C, Lindgren P, et al. Nordic Economic Policy Review 2018: Increasing Income Inequality in the Nordics. TemaNord. 2018.","DOI":"10.6027\/TN2018-519"},{"key":"2965_CR32","doi-asserted-by":"crossref","unstructured":"NIH. National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda M, USA, July 13\u201315, 1987. Arch Neurol. 1988;45:575\u2013578.","DOI":"10.1001\/archneur.1988.00520290115023"},{"key":"2965_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/1359432X.2017.1387536","volume":"27","author":"K Vornholt","year":"2018","unstructured":"Vornholt K, Villotti P, Muschalla B, Bauer J, Colella A, Zijlstra F, et al. Disability and employment\u2014overview and highlights. Eur J Work Organ Psy. 2018;27:40\u201355.","journal-title":"Eur J Work Organ Psy"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02965-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02965-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02965-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T15:03:18Z","timestamp":1699282998000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02965-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2965"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02965-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,6]]},"assertion":[{"value":"21 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study is part of the NF1 research program \u2018Life with NF1\u2019, which was approved by the Danish Protection Agency (Record 2014-41-2935). With reference to the EU General Data Protection Regulation (GDPR), the research project is listed in a local database (2018-DCRC-0012) at the Danish Cancer Society Research Center. The database provides an overview of ongoing research projects involving personal data under the GDPR and replaces the former notification from the Danish Data Protection Agency. As the individuals were not contacted during data collection, no consent to participate was needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"346"}}